Home Featured Page 208

Featured

Latest

Q3’25 Psychedelic Drug Development Pipeline: Bullseye Charts

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale

COMPASS Pathways is granted new US patent for crystalline psilocybin

atai Life Sciences Launches atai Impact, a Philanthropic Program to Harness...

Mycrodose Therapeutics and Nova Mentis Announce LOI to Co-Develop Advanced Drug...

Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in...

Psyched Wellness Announces Preliminary Data Showing Potential New Functional Property and...

Cybin Announces Completion of 74 Pre-Clinical Psychedelic Molecule Studies

First Patient Dosed in Phase IIa DMT-Assisted Therapy Clinical Trial

PT267 – Rebecca Kronman, LCSW – Psychedelics, Pregnancy, and Parenthood

Psychedelic Research Bulletin: September 2021

Psychedelic Bulletin: atai Launches Precision Psychiatry Company; DEA Proposes Further Increase...

1...207208209...296 Page 208 of 296

Q3’25 Psychedelic Drug Development Pipeline: Bullseye Charts

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Q3’25 Psychedelic Drug Development Pipeline: Bullseye Charts

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale

COMPASS Pathways is granted new US patent for crystalline psilocybin

atai Life Sciences Launches atai Impact, a Philanthropic Program to Harness...

Mycrodose Therapeutics and Nova Mentis Announce LOI to Co-Develop Advanced Drug...

Field Trip Health Ltd. Continues Expansion With Psychedelic-Assisted Therapy Centers in...

Psyched Wellness Announces Preliminary Data Showing Potential New Functional Property and...

Cybin Announces Completion of 74 Pre-Clinical Psychedelic Molecule Studies

First Patient Dosed in Phase IIa DMT-Assisted Therapy Clinical Trial

PT267 – Rebecca Kronman, LCSW – Psychedelics, Pregnancy, and Parenthood

Psychedelic Research Bulletin: September 2021

Psychedelic Bulletin: atai Launches Precision Psychiatry Company; DEA Proposes Further Increase...

EDITOR PICKS

Q3’25 Psychedelic Drug Development Pipeline: Bullseye Charts

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY